BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Nektar Therapeutics Presents New Clinical Data From Two Studies Of NKTR-214, A CD122-Biased Agonist, At 2017 ASCO Annual Meeting

  June 5, 2017

   · 

  8 min read
• Primex Pharma At Euroanaesthesia 2017: Next Innovation In The Management Of Paediatric Sedation

  June 5, 2017

   · 

  2 min read
• Drug Development

  Viamet Presents Phase IIb Results Demonstrating Unprecedented Efficacy Of Oral VT-1161 In The Treatment Of Recurrent Vulvovaginal Candidiasis

  June 5, 2017

   · 

  6 min read
• Drug Development

  Janssen-Cilag International NV Release: Darzalex (Daratumumab) Combination Therapy Improved Clinical Outcomes Regardless Of Cytogenetic Risk For Previously-Treated Patients With Multiple Myeloma

  June 5, 2017

   · 

  13 min read
• Drug Development

  Theravance Biopharma Release: New Data Highlighting In Vitro Potency Advantages For VIBATIV (Telavancin) Against Difficult-To-Treat MRSA And MSSA Pathogens Reported At ASM Microbe 2017

  June 5, 2017

   · 

  13 min read
• Drug Development

  Castle Creek Pharma Announces First Patient Enrolled In DELIVERS Study Of Diacerein 1% Ointment For Epidermolysis Bullosa Simplex

  June 5, 2017

   · 

  4 min read
• Business

  Bristol-Myers Squibb And QIAGEN N.V. Partner on Cancer Research

  June 5, 2017

   · 

  1 min read
• Drug Development

  Daiichi Sankyo Release: New Precision Medicine Data On DS-8201 In HER2-Expressing Breast Cancer Revealed At 2017 ASCO Annual Meeting

  June 5, 2017

   · 

  7 min read
• Drug Development

  New Monotherapy Data For Merck & Co.’s KEYTRUDA (Pembrolizumab) In Heavily Pre-Treated Patients With Advanced Gastric Cancer To Be Presented At 2017 ASCO Annual Meeting

  June 5, 2017

   · 

  1 min read
• Drug Development

  Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Yea

  June 5, 2017

   · 

  12 min read